Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.70 -4.61% 14.50 14.00 15.00 15.25 14.50 15.25 207,264 13:01:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -11.1 -4.4 - 36

Futura Medical Share Discussion Threads

Showing 19701 to 19725 of 19725 messages
Chat Pages: 789  788  787  786  785  784  783  782  781  780  779  778  Older
DateSubjectAuthorDiscuss
16/1/2021
05:54
"Anyone detect a nod and a wink on EU approval and/or this deal?" I think they might be more concerned about vaccinating the older community rather than worrying about them achieving an erection. "On the move 2021 is here" Foreclosure or Interpol? ;-)
glavey
16/1/2021
05:23
"You're just clutching at straws..." No Pet, I'm clutching facts.
glavey
15/1/2021
11:35
Spot on yet again, butler! Refusing to ramp past 16p. Ooo look. As I type it drops again! Swing low sweet chariot ........
jonnybig
15/1/2021
11:24
If they go to the market for £10,000.000 has anyone got any idea how much the share value would depreciate ?
msholloway
14/1/2021
16:25
Anyone detect a nod and a wink on EU approval and/or this deal?
j777j
14/1/2021
16:13
On the move 2021 is here
j777j
14/1/2021
15:02
Thanks Butler, your ramblings have now moved the price up!!
duwendag
14/1/2021
15:01
Totally disagree with this comment. Even broker target here is 300% (58p) from September 2020. Many people may have had a toasting here. Some of the AIM sheep jumping ship after the placebo results when this type of placebo happens a lot in trials, safety is key! The cap here is 35m with a 21% float... Many people may have been toasted here hence the vibe on this thread, but this is about to flip... Time will tell the story, if FUM need to place in Q3 at some stage, let that be, they have a block listing too. Dilution on a cap this size is not an issue, also, LO would fully subscribe the placings and they hold 21% already... This will get to market. If you don’t think it will, go and be negative somewhere else. This must be one of the most inexperienced, negative threads on ADVFN.
albert arthur
14/1/2021
14:26
Whatever your interpretation of Q2, FUM has hardly any cash left. I can't see a potential partner giving any money to a company which, even including an upfront payment, has serious going concern problems. The volume continues to dry up and it's simply not breaking through that 16p so, as I've mentioned before, once that 14p offer gets popped it's adios and permanent penny share status then a massive dilution or bankruptcy.
thebutler
14/1/2021
09:57
You're just clutching at straws with your tiresome nitpicking, Glovey.
petroc
14/1/2021
07:47
""The company continues to have sufficient cash resources through to Q2 2021 under current plans" is not Barder setting a cashflow budget, but making a broad statement." And do you think he based it on forecasts presented to him or just stuck his finger in the air? "If he'd have meant the money runs out at the end of March I'm sure his statement would have reflected that." To all intents he did. You just need to read it and correlate, then consider it a warning. "Nobody said that Q2 commences anytime in April/May/June so I don't know why you said that" But you did, Pet, you did. [8216, 8217, 8219, 8220, 8225] "I wouldn't agree that "Q2 2021" means the end of March. I would argue that Q2 means anytime in April/May/June."
glavey
13/1/2021
10:27
"The company continues to have sufficient cash resources through to Q2 2021 under current plans" is not Barder setting a cashflow budget, but making a broad statement. If he'd have meant the money runs out at the end of March I'm sure his statement would have reflected that. Thank you for telling us that jonny barking was correct to say that Q2 starts in 12 weeks, he was also correct in informing us that the share price goes up and down. Both things that we already know but clearly you think worthy of repeating, Glovey. Nobody said that Q2 commences anytime in April/May/June so I don't know why you said that. You say you ignore innuendo but there you are, creating it. I note that you haven't commented on the nutjob's accusation of lying ramper directed at AA, I conclude from that that you endorse the idiot's comment.
petroc
13/1/2021
08:29
Down she goes! Woof woof!
jonnybig
13/1/2021
06:22
When one sets a cashflow budget it has a definite timescale, not 'anytime' Pet. Jonny wrote that Q2 was just 12 weeks away, and indeed it is. It doesn't commence "anytime in April/May/June". I tend to ignore innuendo.
glavey
12/1/2021
17:37
.... and when they were down they were ramped.....
jonnybig
12/1/2021
09:54
Glovey, no, I wouldn't agree that "Q2 2021" means the end of March. I would argue that Q2 means anytime in April/May/June. Not that that's the point I was making. Surely you're not defending jonny nutcase's assertion that AA was a lying ramper for saying Q2 2021 and then quoting exactly the same RNS as proof? He should stick to his nursery rhymes, IMO. At least he gets something correct there - the share price does indeed go up and down like the grand old Duke of York's men. Like every other share, in fact, and hardly something that needs repeating to investors.
petroc
12/1/2021
09:46
Thanks for that, I was looking at that last night.
albert arthur
12/1/2021
09:43
Arthur, the 30p price was before P3 failure and took the hit from that, not the placing. It was roughly half that before the placing, and quickly recovered afterwards.
petroc
12/1/2021
07:45
They appear to have £1.3m wrapped up in the block listing, not sure about, warrants, CLNs or options. But I'll take a look.
albert arthur
12/1/2021
07:33
Yes they have a meeting in Feb with the FDA, pre-trial, pre-approval. As per what I wrote below. Last time they placed, It was fully subscribed at 8p with LO. Price was 30p prior placing and took a hit.
albert arthur
12/1/2021
06:42
AA, keep going with the reading; they haven't started the FDA trial yet! Pet, it's until Q2, meaning end of Q1 surely, wouldn't you agree?
glavey
11/1/2021
22:27
Oh dear, jonny, you really are barking, aren't you. He said q2 2021, and you just repeated it and called him a liar! As I suggested before, when the fun stops, stop.
petroc
11/1/2021
21:44
RNS Number : 0915Z Q2 as per the RNS: Financial highlights • £1.06 million net loss in the period (30 June 2019: net loss £4.46 million). • In May 2020, the company received R&D tax credits of £2.22 million from HMRC with respect to the year ending 2019. • Cash resources of £2.62 million at 30 June 2020 (30 June 2019: £5.63 million). • The company continues to have sufficient cash resources through to Q2 2021 under current plans.
albert arthur
11/1/2021
21:42
Don't know what rns you've been reading, pal,but fum have only got funds left until Q22021, just 12 weeks away. Another lying ramper who's probably the same as the others with a new name. How convenient. Filtered.
jonnybig
11/1/2021
21:29
The difference is the technicalities and the process timescales. Also, FDA have had a pre-submission meeting, further meeting to follow in Feb, now I can’t see them not getting FDA: As per RNS RNS Number : 8130I: “US FDA has agreed to a De Novo medical device application subject to Futura pursuing another” EU could come anytime, I can’t see why they will not get FDA trials, the approval. FUM have funds until Q2 as per RNS: RNS Number : 0915Z. I’d expect the price to be higher then and have a potential partner.
albert arthur
Chat Pages: 789  788  787  786  785  784  783  782  781  780  779  778  Older
ADVFN Advertorial
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210116 21:14:49